Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,563,555
-$664,184 QoQ
Shares Held
106,460
-7.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#857
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Johnson Financial Group, Inc. holds $42,713,684 across 13 Drug Manufacturers - General names. PFE ranks #6 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
54,323 | $13,796,411 | |
| 2 | LLY |
ELI LILLY & Co
|
7,447 | $8,932,155 | |
| 3 | ABBV |
AbbVie Inc.
|
33,931 | $8,538,396 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,390 | $2,748,614 | |
| 5 | AMGN |
Amgen Inc
|
7,380 | $2,672,444 | |
| 6 | PFE |
Pfizer Inc
This page
|
106,460 | $2,563,555 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
16,791 | $2,121,374 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
21,307 | $1,227,708 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,563,555 | 106,460 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $3,227,739 | 114,948 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $3,444,017 | 138,314 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,010,334 | 118,145 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,945,086 | 121,497 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,191,757 | 86,494 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,550,173 | 58,431 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,606,278 | 90,058 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,564,450 | 91,653 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,120,348 | 112,445 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,285,090 | 79,371 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $4,657,000 | 140,398 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,804,859 | 130,994 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,249,654 | 128,668 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,490,365 | 107,150 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,644,072 | 106,126 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,624,738 | 126,354 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,634,841 | 128,160 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,983,441 | 135,198 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,971,335 | 138,836 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $5,819,488 | 148,608 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,063,106 | 139,749 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,100,817 | 111,405 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,271,765 | 116,397 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,801,410 | 85,670 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $4,194,167 | 128,498 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||